EXPERT OPPORTUNITIES

Ed Addison

CEO, Founder, Adviser and Serial Entrepreneur of Disruptive New Ventures, Inspirational Speaker, Author, and Professor

Awards earned

0

1

1

Level:

12 month points:

Total points:

Thought Leader
1190
1257
See More
  • Focus

    Contributions are valued by peers

  • Accountability

    Thoroughly contributes in all areas

  • Sense of Urgency

    Consistently responds in a timely fashion

  • Team

    Frequently supports and responds to peers

Skill demonstrated on Convet.it

Entrepreneurship
Venture Capital
Business Development
Start-ups
Biotechnology
Management
Lifesciences
Consulting
Technology Transfer
Commercialization
Mergers & Acquisitions
Bioinformatics
Strategic Planning
Strategy
Analytics
Public Speaking
Business Planning
Cloud Computing
Drug Discovery
Data Mining
Cross-functional Team Leadership
Innovation Management
Software Development
Informatics
Engineering
E-Learning
University Teaching
Online teaching
Flying
Search Engines
complex systems
Artificial Intelligence
Business Law
menu Summary

Ed Addison, is Chairman and CEO of Cloud Pharmaceuticals, a Research Triangle Park company from Duke University that applies AI to drug design and discovery, achieving unprecedented results. Cloud Pharmaceuticals has designed new drugs in development for cancer and other diseases. Ed is also Chairman of InferenSys, an AI machine learning company under wraps that applies a breakthrough machine learning method to big data, to launch in 2018. With over 30 years experience, Ed is on the advisory board and/or board of directors of a number of companies deploying exponential technologies in life sciences, mobile apps and artificial intelligence, including Global Source Group, VoucherCart, Drug Logic and Parallel Medical Testing.

With a technical background in Artificial Intelligence and a strong business development and capital raising background, Ed is an established serial entrepreneur of disruptive ventures. Ed started 6 companies, funded 4 of them and exited 3. He has twice been named "Entrepreneur of the Year". He has advised 7 venture capital funds and over 20 early stage ventures. His expertise is in launching new technology ventures and new technology products.

Ed is an adjunct professor of engineering management, entrepreneurship and MBA courses. He has previously taught Artificial Intelligence, Computer Science, Systems Engineering and/or Bioinformatics for several universities including NC State University, Stevens Institute of Technology and Johns Hopkins University. Ed holds a BSEE from Virginia Tech, two MS degrees (in Electrical and Biomedical Engineering) from Johns Hopkins, an MBA from Duke University, and an 'online' law degree. He did a sabbatical year at MIT in Artificial Intelligence.

Ed Addison is a multiple repeat early stage venture CEO with successful exits, and is currently building a venture fund in Research Triangle Park.

work Experience

CEO

Cloud Pharmaceuticals, Inc.

November 2010 - Present

Ed is cofounder, CEO and Chairman of Cloud Pharmaceuticals, an established leader in AI based drug discovery. Cloud's mission is to efficiently and rapidly develop new drugs using artificial intelligence and cloud computing using technology originally developed at Duke University. The company is currently developing new drugs for cancer, inflammation, rare diseases, and many others and has stakes in more than 15 new drug programs. The company is under wraps on a massive scale project using a proprietary life sciences data center in Iceland aimed at disrupting the entire industry. Cloud Pharmaceuticals' discovery platform has achieved biological activity on 100% of its drug design programs, has successfully proven its ability to optimize drug lead compounds by computer with successful follow up cell based assay tests, and it has achieved promising animal study results on multiple programs.

Cloud Pharmaceuticals was founded by the confluence of predecessor venture TeraDisc LLC on high performance computing with the research work in the department of chemistry at Duke University. Initially, the company used Virginia Tech's System X supercomputer until it was surpassed by cloud computing. Microsoft provided the initial seed funding for the company, and the University of Florida, via its Gatorade fund, provided the funding for the initial proof of concept in the laboratory. Both programs were highly successful, and the company is now raising institutional capital prior to its intended future IPO.

Lecturer

North Carolina State University

August 2010 - Present

Ed Addison is training the next generation of entrepreneurs and product managers at NC State University. He teaches graduate courses and industry courses in new product launches, product management, innovation, entrepreneurship and business topics for engineers. He has authored a book called "Leveraging the Horizon" on new venture creation, which is now being rewritten and updated under the new title "Creating Your Moonshot" which advocates an approach using "10X Thinking". Ed is also a business plan reviewer at multiple universities.

Managing Partner

Infinity Venture Group

December 2000 - Present

Ed Addison has been a serial entrepreneur since 1990. As a managing partner for Infinity Venture Group, he advises, directs and manages new start up companies for others, particularly high tech ventures spinning out of university settings. Ed is "hands on" with capital raising campaigns. Ed is an established leader for the launch of new high technology products.

Ed is cofounder and Chairman of a new AI machine learning company called InferenSys with a novel probabilistic reasoning technology over big data, which will enter the market in 2018. He is adviser to pharmacogenomics venture Parallel Medical Testing; to genomics venture Wobblebase; to UK-based mobile app venture Global Source Group; to UK-based e-commerce company VoucherCart, and is actively engaged in business development for drug safety company Drug Logic.

Ed previously worked with TeraDiscoveries (a life sciences high performance computing company), Inclinix ( a search engine based clinical trials recruiting company), Lexxle aka BioSequent (a bioinformatics and AI company), BioFortis (a LIMS company), and Lessac Technologies (a voice synthesis company, where he was co founder and inventor).

He was previously a member of the executive investment committee at venture capital firm Next Generation Funds, advisor to Incube8 and Maryland TAP business incubator programs, a limited partner in venture funds Boulder Fund 1 &2, and Sands Brothers Fund 2, and was a business plan judge for Johns Hopkins University, UNCW and Duke University.

Adjunct Faculty in New Business Ventures and Entrepreneurship

Jack Welch Management Institute

September 2017 - Present

Ed teaches MBA subjects including new Business Ventures and Entrepreneurship in the MBA program at JWMI. This program is the #20 global online MBA and the fastest growing MBA in the world.


Domains of experience:

Entrepreneurship
Venture Capital
Business Development
Start-ups
Biotechnology
Management
Lifesciences
Consulting
Technology Transfer
Commercialization
Mergers & Acquisitions
Bioinformatics
Strategic Planning
Strategy
Analytics
Public Speaking
Business Planning
Cloud Computing
Drug Discovery
Data Mining
Cross-functional Team Leadership
Innovation Management
Software Development
Informatics
Engineering
E-Learning
University Teaching
Online teaching
Flying
Search Engines
complex systems
Artificial Intelligence
Business Law
stars Convetit Experience

Since 10/2017

Participating on a Discovery Board on

Artificial Intelligence
Life Sciences
Machine Learning
Algorithms
Biotechnology
Pharmaceutical Industry

12/2016 - 05/2017

Participated on a Discovery Board on

Invesment Management
Startup
Angel Investing & VC
Private Equity
Venture Capital
Entrepreneur
Intrapreneur
Corporate Venture Capital
Start-ups
Accelerators

Recent Open Board Activity:

check_circle

Answered a question on the "Other" Open Board

Leadership
Management
Project Management
Strategy
Strategic Planning
Microsoft Office
Business Strategy
check_circle

Answered a question on the "Other" Open Board

Leadership
Management
Project Management
Strategy
Strategic Planning
Microsoft Office
Business Strategy
check_circle

Answered a question on the "Future of Block Chain Technology as it pertains to Health care" Open Board

Blockchain Technology
Blockchain Technologies
Healthcare
Healthcare Information Technology
Distributed Ledger Technology
Pharmaceutical Industry
Health Education
Hospitals
Patient Education
Healthcare Industry
Real Estate Development
check_circle

Answered a question on the "Cybersecurity " Open Board

Cyber-security
Cyber Security
Cybercrime
Cyber Defense
Cybersecurity
Retail
Financial Services
Machine Learning
Relationship Management
Artificial Intelligence
Competitive Intelligence
Pricing Strategy
check_circle

Answered a question on the "Financial Services Investment Banking" Open Board

Banking
Financial Services
Financial Analysis
Finance
Financial Modeling
Investment Banking
Investment Strategies
Banking Law
Business Development
Strategic Planning
Start-ups
Business Planning
Entrepreneurship
Mergers & Acquisitions
Continuous Improvement